Annemiek J. de Boer - Concepedia

Author

Annemiek J. de Boer

Also Known As

A J de Boer, A. J. de Boer, A.J. de Boer, Annemiek J de Boer, Annemiek J. De Boer, Annemiek J. de Boer, Annemiek J. de Boer

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center The Netherlands Cancer Institute Amsterdam UMC Location University of Amsterdam Oncode Institute

About

Annemiek J. de Boer is an author at Radboud University Nijmegen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Immunology	11	11	1.6K
3	Cell Biology	9	9	1.5K
4	Allergy	2	2	409
5	Molecular Genetics	1	1	20

Annemiek J. de Boer

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. Alexander B. H. Bakker, Marco W.J. Schreurs, Annemiek J. de Boer, The Journal of Experimental Medicine Gp100 CdnaImmunologyPathologyAntigen ProcessingImmunotherapy	1994	579
Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Andreas A. O. Eggert, Marco W.J. Schreurs, Otto C. Boerman, PubMed ImmunologyImmunoeditingMurine Dendritic CellsImmunotherapyIndium-111-labeled Dcs	1999	281
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Clinical Cancer Research	2015	231
Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. E. van de Wiel-van Kemenade, M J Ligtenberg, Annemiek J. de Boer, The Journal of Immunology	1993	222
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Clinical Cancer Research	2011	187
Molecular characterization of the melanocyte lineage-specific antigen gp100. Gosse J. Adema, Annemiek J. de Boer, Arthur Vogel, Journal of Biological Chemistry	1994	169
Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Alexander B. H. Bakker, G. Marland, Annemiek J. de Boer, PubMed ImmunologyAntigen ProcessingImmunotherapeuticsImmunotherapyPeptide-loaded Dendritic Cells	1995	161
Identification of a novel peptide derived from the melanocyte‐specific gp100 antigen as the dominant epitope recognized by an HLA‐A2.1‐restricted anti‐melanoma CTL line Alexander B. H. Barker, Marco W.J. Schreurs, Gaalda Tafazzul, International Journal of Cancer ImmunologyDominant EpitopeImmunologic MechanismAntigen ProcessingImmunotherapeutics	1995	128
Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Marco W.J. Schreurs, Andreas A. O. Eggert, Annemiek J. de Boer, PubMed ImmunologyImmunotherapeuticsDermatologyImmunotherapyTumor Biology	2000	127
Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Gosse J. Adema, Annemiek J. de Boer, Rianne van 't Hullenaar, PubMed	1993	104

Page 1